Traders sold shares of UnitedHealth Group Inc (NYSE:UNH) on strength during trading hours on Thursday. $167.38 million flowed into the stock on the tick-up and $217.73 million flowed out of the stock on the tick-down, for a money net flow of $50.35 million out of the stock. Of all equities tracked, UnitedHealth Group had the 0th highest net out-flow for the day. UnitedHealth Group traded up $4.10 for the day and closed at $229.48
Several equities research analysts have weighed in on the company. Cantor Fitzgerald reiterated a “buy” rating and issued a $280.00 target price on shares of UnitedHealth Group in a report on Thursday, March 8th. Barclays assumed coverage on UnitedHealth Group in a report on Thursday, March 8th. They issued an “overweight” rating and a $265.00 target price for the company. Credit Suisse Group reiterated a “buy” rating on shares of UnitedHealth Group in a report on Friday, March 9th. Citigroup upped their target price on UnitedHealth Group from $235.00 to $268.00 and gave the stock a “buy” rating in a report on Wednesday, January 17th. Finally, Oppenheimer upped their target price on UnitedHealth Group from $215.00 to $225.00 and gave the stock an “outperform” rating in a report on Wednesday, November 29th. Two investment analysts have rated the stock with a hold rating and twenty-six have given a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus target price of $245.14.
The stock has a market cap of $218,091.88, a PE ratio of 21.28, a P/E/G ratio of 1.31 and a beta of 0.74. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.58.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, March 20th. Investors of record on Friday, March 9th will be given a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a yield of 1.32%. The ex-dividend date of this dividend is Thursday, March 8th. UnitedHealth Group’s dividend payout ratio is currently 28.01%.
In related news, Director Kenneth Irwin Shine sold 198 shares of the company’s stock in a transaction dated Friday, January 19th. The stock was sold at an average price of $242.55, for a total transaction of $48,024.90. Following the transaction, the director now directly owns 1,790,567 shares of the company’s stock, valued at approximately $434,302,025.85. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Richard T. Burke sold 10,400 shares of the company’s stock in a transaction dated Thursday, March 1st. The shares were sold at an average price of $229.87, for a total value of $2,390,648.00. Following the transaction, the director now directly owns 1,781,657 shares in the company, valued at $409,549,494.59. The disclosure for this sale can be found here. Insiders have sold a total of 30,598 shares of company stock worth $7,280,073 over the last ninety days. 0.89% of the stock is currently owned by corporate insiders.
A number of large investors have recently made changes to their positions in UNH. Beach Investment Management LLC. purchased a new stake in UnitedHealth Group during the 2nd quarter valued at about $556,000. Almanack Investment Partners LLC. purchased a new stake in UnitedHealth Group during the 2nd quarter valued at about $158,000. Dai Ichi Life Insurance Company Ltd grew its stake in UnitedHealth Group by 8.9% during the 2nd quarter. Dai Ichi Life Insurance Company Ltd now owns 163,914 shares of the healthcare conglomerate’s stock valued at $30,393,000 after purchasing an additional 13,432 shares during the last quarter. Northwestern Mutual Wealth Management Co. grew its stake in UnitedHealth Group by 5.2% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 94,199 shares of the healthcare conglomerate’s stock valued at $17,465,000 after purchasing an additional 4,691 shares during the last quarter. Finally, Oak Ridge Investments LLC grew its stake in UnitedHealth Group by 4.6% during the 2nd quarter. Oak Ridge Investments LLC now owns 138,326 shares of the healthcare conglomerate’s stock valued at $25,648,000 after purchasing an additional 6,097 shares during the last quarter. 86.83% of the stock is currently owned by institutional investors.
ILLEGAL ACTIVITY NOTICE: “Investors Sell UnitedHealth Group (UNH) on Strength (UNH)” was posted by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this report on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The original version of this report can be accessed at https://stocknewstimes.com/2018/03/17/investors-sell-unitedhealth-group-unh-on-strength-unh.html.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.